- About
- Cancers Treated
- Treatment
- Research & Clinical Trials
- Meet the Team
Hoag Family Cancer Institute provides comprehensive, multidisciplinary care for blood cancers - from early detection to advanced therapies.
Hematologic Cancers We Treat
Lymphoma
Lymphoma is a blood-related cancer that occurs in the lymphocytes, which are a type of white blood cell. There are two main types: Hodgkin lymphoma and Non-Hodgkin lymphoma.
Leukemia
Leukemia is a type of cancer which occurs in cells of the body that help create blood, including cells in the lymphatic system and bone marrow.
Myeloma
Also known as “multiple myeloma,” myeloma is a cancer of specialized white blood cells that make up plasma. In patients with myeloma, impacted cells grow out of control, forcing out the normal bone marrow cells that make platelets, red blood cells, and other forms of white blood cells.
Myelodysplastic syndrome
Myelodysplastic syndrome (MDS) is a group of conditions that impact the ability of the body to make new, healthy blood cells.
Myeloproliferative neoplasms
Myeloproliferative neoplasms (MPN) are a group of blood cancers in which a person’s bone marrow makes too many of a certain type of blood cell, or makes blood cells that don’t mature properly.
Winning Against Hematologic Malignancies

Offering Molecular Imaging Trial for Myeloma

Your journey starts here
1
Find the right provider
Get care from medical providers that fit your needs in a location near you.
Find a provider2
3
Get in touch
Didn’t see what you’re looking for? Reach out and we’ll make sure you get what you need.
Contact UsHematologic Cancers Treated
Lymphoma
Hoag offers leading expertise in lymphoma and blood cancers, delivered by a highly experienced multidisciplinary team supported by world-class diagnostics, molecular imaging, and nationally recognized specialists. Patients have access to advanced treatments including immunotherapy, chemotherapy, radiation therapy, precision medicine, and CAR-T cell therapy, one of the most innovative options available for relapsed or refractory disease.
Leukemia
A leukemia diagnosis can be overwhelming, and hard to understand. At Hoag Family Cancer Institute, we're committed to caring for body, mind and soul, helping patients navigate the process of healing with less confusion and more agency. From next-generation treatments to our dedicated clinical nurse navigators to help patients find resources and information, we're here for you.
Myelodysplastic Syndrome
A myelodysplastic syndrome diagnosis is news nobody wants to get, but Hoag is ready to help you understand your treatment options, mitigate symptoms and find your best path forward. Our whole-body approach brings together the best research, technology and treatment options along with a world-class team of physicians with one goal in mind: to see you as more than just a diagnosis, and help you see a future beyond your condition.
Myeloma
Hoag offers leading expertise in myeloma and blood cancers, delivered by a highly experienced multidisciplinary team supported by world-class diagnostics, molecular imaging, and nationally recognized specialists. Patients have access to advanced treatments including immunotherapy, chemotherapy, radiation therapy, precision medicine, and CAR-T cell therapy, one of the most innovative options available.
Myeloproliferative Neoplasms
Myeloproliferative neoplasms are very rare, with only around 20,000 total cases diagnosed in the U.S. each year according to the National Cancer Institute. As the highest-volume cancer center in Orange County, Hoag sees and treats more blood cancer cases, including rare types like myeloproliferative neoplasms.
Hematologic Cancers Treatments
Chemotherapy/Systemic Therapy
Chemotherapy uses powerful drugs or chemicals to directly attack cancerous cells. Systemic Therapy is a non-surgical treatment option for cancer patients. Systemic therapy is when drugs are administered into a patient’s blood stream to stop or slow the growth of cancerous cells. Biological therapy, also referred to as “Immunotherapy” utilizes the body immune system to fight cancer cells.
Cell Therapy
One of only 2 providers in OC to offer CAR-T cell therapy, Hoag offers transformative cell therapy for lymphoma, myeloma, and certain solid tumors. Hoag is the first in Orange County to offer this innovative, FDA-approved therapy for malignant blood and lymphatic cancers, and was also the first to provide cell therapy for solid tumors through its robust clinical research program.
Infusion Therapy
The Hoag Infusion Center provides care for all Hoag patients who need intravenous infusions, blood products, or medical injections. Our experienced infusion staff works closely with the patient’s physician to provide comprehensive care.
Precision Medicine Program
Hoag’s Precision Medicine Program combines genomics and genetics to diagnose, treat, and prevent diseases. Using the latest advances in genomic technologies, targeted therapies and research, our precision medicine program brings together a multidisciplinary team, including a robust genetic counseling group of experts, to provide patients with the latest in innovation and technology.
Tumor Boards
Tumor boards* are a meeting of Hoag’s top experts in their respective subspecialties to determine the best approach for a patient’s individual cancer case.
Palliative Care
Palliative care is a specialty that focuses on improving the quality of life of individuals facing serious illness through medical management and emotional support.
Research & Clinical Trials for Hematologic (Blood Cancers)
Hoag is committed to leading the way in state-of-the-art technologies and advanced treatment options. Part of this commitment includes clinical research with the goal of helping patients live longer, healthier lives. Through carefully planned clinical trials, researchers evaluate the safety and effectiveness of new ways to diagnose, treat and prevent diseases or conditions. Treatments studied in clinical trials might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments.
Meet Hoag's Hematologic (Blood) Cancer and Benign Hematology Team
Hematologic (Blood) Cancer and Benign Hematology Medical Oncologists

Robert M. Carroll, MD
Medical Oncology

Benjamin H. Goldenson, MD
Medical Oncology

Yaser Homsi, MD
Medical Oncology

Sharmeen Mahmood, DO
Medical Oncology

Pooja Motwani, MD
Medical Director, Benign and Malignant Hematology

Eric Zhuang, MD
Medical Oncology

Raghuveer Ranganathan, MD
Program Director, Immune Effector and Cellular Therapy
Eduardo Fernandez Hernandez, MD
Medical Oncology
Radiation Oncologists

Craig A. Cox, MD
Medical Director, Radiation Oncology Program

Peter V. Chen, MD
Radiation Oncology

Brian S. Kim, MD
Radiation Oncology

Kevin Lin, MD
Radiation Oncology

Shane A. Lloyd, MD
Radiation Oncology
Hematologic (Blood) Cancer and Benign Hematology Nurse Navigator

Jennifer Lozano, BSN, RN
Clinical Nurse Navigator
Hoag's Precision Medicine Program
Hoag’s Precision Medicine Program combines genomics and genetics to diagnose, treat, and prevent diseases. Using the latest advances in genomic technologies, targeted therapies and research, our precision medicine program brings together a multidisciplinary team, including a robust genetic counseling group of experts, to provide patients with the latest in innovation and technology.
Hoag Family Cancer Institute Social Workers
Being diagnosed with cancer can feel overwhelming at times. Many patients and their families need help with coping and can benefit from supportive counseling. Oncology Clinical Social Workers are available to provide emotional and practical support during all stages of cancer including diagnosis, treatment and post-treatment survivorship.
Hoag Family Cancer Institute Dietitians
Hoag Family Cancer Institute dietitians work closely with patients’ physicians, nurses, therapists, and social workers to ensure complete care.
Stay up-to-date on the latest news from Hoag
By submitting this request, you agree to receive communications from Hoag and accept our Privacy Policy and Terms of Use.